Selective IL-2 responsiveness of regulatory t cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes

Aixin Yu, Isaac Snowhite, Francesco Vendrame, Michelle Rosenzwajg, David Klatzmann, Alberto Pugliese, Thomas R. Malek

Research output: Contribution to journalArticlepeer-review

107 Scopus citations

Fingerprint

Dive into the research topics of 'Selective IL-2 responsiveness of regulatory t cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes'. Together they form a unique fingerprint.

Medicine & Life Sciences